Drinalizumab
Jump to navigation
Jump to search
Drinalizumab is a humanized monoclonal antibody which it is used as an immunosuppresive drug and it is used to treat Type 1 diabetes.
Drinalizumab is a humanized monoclonal antibody which it is used as an immunosuppresive drug and it is used to treat Type 1 diabetes.
This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. |